"Association of CYP2C19 genotype with type 2 diabetes"
written by Carlos Hoyo-Vadillo, Jaime Garcia-Mena, Adán Valladares, Caterina R. Venturelli, Niels Wacher-Rodarte, Jesús Kumate, Miguel Cruz,
published by Health, Vol.2 No.10, 2010
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] CYTOCHROME P450 CYP1B1* 2 GENE AND ITS ASSOCIATION WITH T2D IN TABUK POPULATION, NORTHWESTERN REGION OF SAUDI ARABIA
2018
[2] Risk factors for cardiovascular disease in Mexican adults
2018
[3] Cytochrome P450: Polymorphisms and roles in Cancer, Diabetes and Atherosclerosis
Asian Pacific journal of cancer prevention: APJCP, 2018
[4] Revista Médica
2017
[5] CYP2C19 activity and cardiovascular risk factors in patients with an acute coronary syndrome
Medicina Clínica (English Edition), 2017
[6] Factores de riesgo para enfermedad cardiovascular en adultos mexicanos/Risk factors for cardiovascular disease in Mexican adults
Revista Medica MD, 2017
[7] Actividad de CYP2C19 y factores de riesgo cardiovascular en pacientes con síndrome coronario agudo
Medicina Clínica, 2017
[8] Oporność na leki przeciwpłytkowe: przyczyny i możliwości diagnostyki
Problemy Nauk Stosowanych, 2016
[9] CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy
The Pharmacogenomics Journal, 2015
[10] Genetic variability of CYP2C19 in a Mexican population: contribution to the knowledge of the inheritance pattern of CYP2C19* 17 to develop the ultrarapid metabolizer …
Journal of Genetics, 2015
[11] Genetic variability of CYP2C19 in a Mexican population: contribution to the knowledge of the inheritance pattern of CYP2C19* 17 to develop the ultrarapid metabolizer phenotype
Journal of genetics, 2015
[12] Genetic variability of CYP2C19 in a Mexican population: contribution to the knowledge of the inheritance pattern of CYP2C19*17 to develop the ultrarapid …
Journal of Genetics, 2015
[13] 糖尿病状态下CYP450s 酶活性改变及其在糖尿病病情发展中的作用
中国药科大学学报, 2014
[14] Oporność na leki przeciwpłytkowe u pacjentów z chorobami układu krążenia i cukrzycą Resistance to antiplatelet drugs in patients with cardiovascular diseases and diabetes
W Piechota - pnmedycznych.pl, 2014
[15] Genetic variability of CYP2C19 in a Mexican population: Contribution to the knowledge of the inheritance pattern of CYP2C19* 17 to develop the ultra-rapid metabolizer phenotype
JSF HERNANDEZ-ZARAGOZA, J FRANCISCO… - ias.ac.in, 2014
[16] 糖尿病状态下 CYP450s 酶活性改变及其在糖尿病病情发展中的作用
2014
[17] Resistance to antiplatelet drugs in patients with cardiovascular diseases and diabetes
Postępy Nauk Medycznych, 2013
[18] Demographic Differences by Age, BMI, Gender and Disease States of Phase I and Phase II Enzyme Activities in Cryopreserved Human Hepatocytes
T Moeller, S Dennell, T Rose, C Watt - ww.bioreclamation.com, 2013
[19] Cytochrome P450 genetic polymorphisms of Mexican indigenous populations
Drug metabolism and drug interactions, 2013
[20] Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico
Genetic testing and …, 2012
[21] Impact of clopidogrel treatment on platelet function and thrombogenecity in diabetic patients undergoing elective coronary stenting
Journal of Diabetes Mellitus, 2012
[22] Distribution of
2012